| pubmed-article:1523157 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1523157 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:1523157 | lifeskim:mentions | umls-concept:C0033325 | lld:lifeskim |
| pubmed-article:1523157 | lifeskim:mentions | umls-concept:C0543467 | lld:lifeskim |
| pubmed-article:1523157 | lifeskim:mentions | umls-concept:C0031511 | lld:lifeskim |
| pubmed-article:1523157 | lifeskim:mentions | umls-concept:C0001721 | lld:lifeskim |
| pubmed-article:1523157 | lifeskim:mentions | umls-concept:C1149475 | lld:lifeskim |
| pubmed-article:1523157 | lifeskim:mentions | umls-concept:C1522326 | lld:lifeskim |
| pubmed-article:1523157 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:1523157 | pubmed:issue | 4-5 | lld:pubmed |
| pubmed-article:1523157 | pubmed:dateCreated | 1992-10-15 | lld:pubmed |
| pubmed-article:1523157 | pubmed:abstractText | 89 patients were operated upon for pheochromocytoma. 61 patients (37 women and 24 men) were available for follow-up. Mean age at operation was 39 +/- 12.3 yrs. Before operation paroxysmal and sustained hypertension were observed in 34 (55.7%) and 27 (44.3%) patients, respectively. Postoperatively permanent normalization of blood pressure was achieved in 38 cases (62.3%). All patients were divided into four groups. Group I with increased urine excretion of noradrenaline (NA) and adrenaline (A) consisted of 19 (31.1%) patients. Group II (increased NA excretion) included 27 (44.3%) patients. Group III comprised 3 (4.9%) cases with elevated A excretion. 12 (19.7%) patients with normal urinary excretion of catecholamines and increased excretion of methoxycatecholamines were alloted to group IV. Permanent normalization of blood pressure predominantly was observed in group IV--91.6%, whilst in group I, II and III this hypotensive effect was noted in 57.9%, 51.8% and 2/3, respectively. Permanent normalization of blood pressure can be mainly expected in patients with pheochromocytoma in whom catecholamines are rapidly inactivated within the tumor. | lld:pubmed |
| pubmed-article:1523157 | pubmed:language | pol | lld:pubmed |
| pubmed-article:1523157 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1523157 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1523157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1523157 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1523157 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1523157 | pubmed:issn | 0032-3772 | lld:pubmed |
| pubmed-article:1523157 | pubmed:author | pubmed-author:JanuszewiczWW | lld:pubmed |
| pubmed-article:1523157 | pubmed:author | pubmed-author:ChodakowskaJJ | lld:pubmed |
| pubmed-article:1523157 | pubmed:author | pubmed-author:WocialBB | lld:pubmed |
| pubmed-article:1523157 | pubmed:author | pubmed-author:FeltynowskiTT | lld:pubmed |
| pubmed-article:1523157 | pubmed:author | pubmed-author:PruszczykPP | lld:pubmed |
| pubmed-article:1523157 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1523157 | pubmed:volume | 87 | lld:pubmed |
| pubmed-article:1523157 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1523157 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1523157 | pubmed:pagination | 299-305 | lld:pubmed |
| pubmed-article:1523157 | pubmed:dateRevised | 2010-4-1 | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:meshHeading | pubmed-meshheading:1523157-... | lld:pubmed |
| pubmed-article:1523157 | pubmed:articleTitle | [Does hormonal activity of pheochromocytoma affect long-term prognosis in surgically treated patients?]. | lld:pubmed |
| pubmed-article:1523157 | pubmed:affiliation | Kliniki Nadci?nienia Tetniczego i Chorób Naczy? AM, Warszawie. | lld:pubmed |
| pubmed-article:1523157 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1523157 | pubmed:publicationType | English Abstract | lld:pubmed |
